通过受控的免疫球蛋白基因重组生成单克隆抗体
Akiho Murayama1, Shin Matsui1, Takuya Abe2
1Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.
Communications biology
|February 26, 2025
概括
研究人员开发了一种稳定抗原特异单克隆抗体 (mAbs) 的新方法. 通过使用辅酶诱导降解系统控制激活诱导脱氨酶 (AID),他们停止了基因转换,防止了mAb特异性的不必要变化.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 单克隆抗体 (mAbs) 对研究,诊断和治疗至关重要.
- 稳定生成抗原特异性mAbs对于可靠的应用至关重要.
- ADLib系统使用鸟类DT40 B细胞通过基因转换生成mAb.
研究的目的:
- 为了提高ADLib系统产生的抗原特异性B细胞克隆的稳定性.
- 为了防止自发的基因转换,可以改变mAb的特异性.
- 设计一种在鸟类B细胞中进行受控基因转换的方法.
主要方法:
- 使用辅酶诱导降解系统,对激活诱导的除氨酶 (AID) 进行了工程条件突变.
- 利用依赖于辅素的基-蛋白酶体通路来降解AID蛋白质.
- 应用了修改后的ADLib系统与AID条件突变用于mAb生成.
主要成果:
- 此外,auxin成功降解了被降解标记的AID蛋白质,阻止了基因转换.
- 工程系统有效地稳定了抗原特异性克隆.
- 通过使用稳定克隆成功分离了抗原特异性mAbs.
结论:
- 有条件的AID突变为产生和稳定抗原特异性克隆提供了强大的工具.
- 这种方法提高了mAb发电平台的可靠性和一致性.
- 该方法解决了自发多样化的问题,提高了衍生MABS的质量.
相关概念视频
01:31Hybridoma Technology
14.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.0K
01:25Antibody Structure and Classes
735
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
735